LOS ANGELES, Sept. 3, 2024 /PRNewswire/ —
The Schall Law Firm, a national shareholder rights litigation firm, alerts investors to a potential class action lawsuit against Lifecore Biomedical, Inc. (“Lifecore” or “the Company”) LFCR for alleged violations of securities laws.
Class Action Allegations
Investors who bought Lifecore’s securities between October 7, 2020 and March 19, 2024 (the “Class Period”) are urged to reach out to the law firm before September 27, 2024.
Legal Consultation
Shareholders who faced losses during this period can participate in the case and consult with Brian Schall of the Schall Law Firm to understand their rights without any charges.
The firm emphasizes that until the class is certified, investors are not represented by an attorney. Those opting for no action can still be considered as absent class members.
The case pertains to allegations that Lifecore misled the market by not maintaining proper internal controls over financial reporting. The company issued inaccurate financial statements and did not rectify its flaws. This led to non-compliance issues with NASDAQ listing requirements, including delayed filing of financial reports with the SEC. Ultimately, these actions allegedly caused damages to investors when the truth came to light.
Seeking Recovery
Interested parties are encouraged to join the case to potentially recover their losses.
About The Schall Law Firm
Specializing in securities class action lawsuits and shareholder rights litigation, The Schall Law Firm serves investors worldwide.
Note: This press release may be considered Attorney Advertising in certain jurisdictions as per the applicable law and ethics rules.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com